PTJ
CLBT icon

Paul Tudor Jones’s Cellebrite CLBT Stock Holding History

Paul Tudor Jones’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-151,538
Closed -$2.09M – 3639
2026
Q1 		$2.09M Buy
151,538
+79,457
+110% +$1.2M ﹤0.01% 1818
2025
Q4 		$1.3M Buy
+72,081
New +$1.29M ﹤0.01% 2101
2025
Q3 		– Sell
-453,815
Closed -$7.26M – 3416
2025
Q2 		$7.26M Sell
453,815
-88,210
-16% -$1.57M 0.02% 863
2025
Q1 		$10.5M Buy
542,025
+5,903
+1% +$124K 0.04% 437
2024
Q4 		$11.8M Buy
536,122
+53,832
+11% +$1.04M 0.04% 288
2024
Q3 		$8.12M Buy
482,290
+6,490
+1% +$96.3K 0.03% 494
2024
Q2 		$5.69M Sell
475,800
-90,162
-16% -$1.01M 0.03% 611
2024
Q1 		$6.27M Buy
565,962
+153,623
+37% +$1.57M 0.04% 511
2023
Q4 		$3.57M Buy
+412,339
New +$3.2M 0.03% 806

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Paul Tudor Jones's CLBT Position: Q2 2026 in Review

Paul Tudor Jones sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 151,538 shares — an estimated $2.09M sold.

Paul Tudor Jones first reported a position in CLBT in Q4 2023 and held it in 9 quarters. The position peaked at $11.8M in Q4 2024. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Paul Tudor Jones reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 151,538 Cellebrite shares in Q2 2026, an estimated $2.09M.
  • Paul Tudor Jones first reported a position in Cellebrite in Q4 2023 and held it in 9 quarters.
  • Paul Tudor Jones's Cellebrite position peaked at $11.8M in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.